|
CA2907839A1
|
|
Synthesis of dabigatran
|
|
CA2827275A1
|
|
Copolymer-1, process for preparation and analytical methods thereof
|
|
WO2012042542A1
|
|
Process for preparation of crosslinked polymer
|
|
EP2428511A1
|
|
Synthesis of dronedarone and salts thereof
|
|
EP2609099A2
|
|
Sitagliptin, salts and polymorphs thereof
|
|
US2011263579A1
|
|
Chlorothiazide, chlorothiazide salts and pharmaceutical compositions thereof
|
|
US2011064820A1
|
|
Pharmaceutical compositions comprising phosphate-binding polymer
|
|
CA2781826A1
|
|
Controlled release pharmaceutical compositions of galantamine
|
|
EP2364967A2
|
|
Process for preparation of rasagiline and salts thereof
|
|
CA2749397A1
|
|
Pharmaceutical compositions comprising phosphate-binding polymer
|
|
EP2356240A2
|
|
Novel synthetic expression vehicle
|
|
KR20110059750A
|
|
Crosslinked polymers
|
|
CA2741209A1
|
|
An improved process for pegylation of proteins
|
|
US2012035117A1
|
|
Process for synthesis of cyclic octapeptide
|
|
EP2262841A2
|
|
Process for preparation of amine polymer salt
|
|
EP2150528A2
|
|
Process for preparation of proguanil hydrochloride
|
|
BRPI0803070A2
|
|
polypeptide, polynucleotide sequence, recombinant expression vector, host cell, and process for producing and purifying a recombinant protein
|
|
EP2187874A2
|
|
Sustained release compositions of trimetazidine and process for preparation thereof
|
|
BRPI0810168A2
|
|
Pharmaceutical compositions of clopidogrel bisulphate and preparation processes
|
|
WO2008093360A2
|
|
A process for preparation of (s)-(+)-n-methyl-3(1-naphthyloxy)-3(2-thienyl)propylamine hydrochloride
|
